- Home
- APP vs ABT Comparison
APP vs ABT Comparison
Compare APP & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APP
- ABT
- Stock Information
- Founded
- APP 2012
- ABT 1888
- Country
- APP United States
- ABT United States
- Employees
- APP N/A
- ABT N/A
- Industry
- APP EDP Services
- ABT Medical/Dental Instruments
- Sector
- APP Technology
- ABT Health Care
- Exchange
- APP Nasdaq
- ABT Nasdaq
- Market Cap
- APP 188.5B
- ABT 222.8B
- IPO Year
- APP 2021
- ABT N/A
- Fundamental
- Price
- APP $537.84
- ABT $127.84
- Analyst Decision
- APP Strong Buy
- ABT Strong Buy
- Analyst Count
- APP 19
- ABT 18
- Target Price
- APP $708.67
- ABT $146.61
- AVG Volume (30 Days)
- APP 4.7M
- ABT 6.2M
- Earning Date
- APP 11-05-2025
- ABT 10-15-2025
- Dividend Yield
- APP N/A
- ABT 1.85%
- EPS Growth
- APP 144.05
- ABT 141.97
- EPS
- APP 7.98
- ABT 7.96
- Revenue
- APP $6,307,450,000.00
- ABT $43,843,000,000.00
- Revenue This Year
- APP $20.00
- ABT $7.55
- Revenue Next Year
- APP $33.60
- ABT $7.70
- P/E Ratio
- APP $70.12
- ABT $15.98
- Revenue Growth
- APP 98.48
- ABT 6.37
- 52 Week Low
- APP $200.50
- ABT $110.86
- 52 Week High
- APP $745.61
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- APP 41.85
- ABT 50.94
- Support Level
- APP $489.30
- ABT $122.10
- Resistance Level
- APP $564.80
- ABT $129.52
- Average True Range (ATR)
- APP 37.72
- ABT 2.74
- MACD
- APP -5.55
- ABT 0.22
- Stochastic Oscillator
- APP 26.90
- ABT 60.78
About APP Applovin Corporation
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.